Respiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
Department of Chemistry, University of Ioannina, Ioannina, Greece.
Adv Exp Med Biol. 2021;1337:1-7. doi: 10.1007/978-3-030-78771-4_1.
Chronic obstructive pulmonary disease (COPD) is a common disease that causes long-term disability and death. Its natural history is punctuated by acute worsening of symptoms, called exacerbations, which are associated with increased mortality and hospitalization. In this work, we aim to stratify patients with COPD based on their risk for exacerbation; for this purpose, we employ non-invasive biomarkers, that is, volatile organic compounds (VOCs), acquired from the patients' exhaled breath coupled with their spirometry and age. We utilize a series of classification schemes with the best performing one achieving overall Accuracy = 93.5%. The yielded results are, therefore, encouraging and prompt for further investigation toward the utilization of VOCs in the management of COPD.
慢性阻塞性肺疾病(COPD)是一种常见的疾病,可导致长期残疾和死亡。其自然病程以症状急性加重为特征,称为加重,与死亡率和住院率增加有关。在这项工作中,我们旨在根据 COPD 患者的加重风险对其进行分层;为此,我们使用非侵入性生物标志物,即从患者呼气中获得的挥发性有机化合物(VOCs),并结合其肺活量测定和年龄进行分析。我们使用了一系列分类方案,表现最好的方案达到了总体准确率=93.5%。因此,这些结果令人鼓舞,并促使进一步研究利用 VOCs 来管理 COPD。